#,ama,title,journal,year,volume,issue,pages,doi,pmid,authors
1,"Shen KR, Bribriesco A, Crabtree T. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017;153.",The American Association for Thoracic Surgery consensus guidelines for the management of empyema,J Thorac Cardiovasc Surg,2017,153,,,,,Shen KR; Bribriesco A; Crabtree T
2,Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc. 2006;3.,Parapneumonic effusions and empyema,Proc Am Thorac Soc,2006,3,,,,,Light RW
3,"Davies HE, Davies RJ, Davies CW, Disease G, Group. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(suppl 2).",Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010,Thorax,2010,65,suppl 2,,,,Davies HE; Davies RJ; Davies CW; Disease G; Group
4,"Idell S, Florova G, Shetty S. Precision-guided, personalized intrapleural fibrinolytic therapy for empyema and complicated parapneumonic pleural effusions: the case for the fibrinolytic potential. Clin Pulm Med. 2017;24.","Precision-guided, personalized intrapleural fibrinolytic therapy for empyema and complicated parapneumonic pleural effusions: the case for the fibrinolytic potential",Clin Pulm Med,2017,24,,,,,Idell S; Florova G; Shetty S
5,"Maskell NA, Davies CW, Nunn AJ. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005;352.",Controlled trial of intrapleural streptokinase for pleural infection,N Engl J Med,2005,352,,,,,Maskell NA; Davies CW; Nunn AJ
6,"Rahman NM, Maskell NA, West A. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365.",Intrapleural use of tissue plasminogen activator and DNase in pleural infection,N Engl J Med,2011,365,,,,,Rahman NM; Maskell NA; West A
7,"Alemán C, Alegre J, Monasterio J. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions. Clin Sci (Lond). 2003;105.",Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions,Clin Sci (Lond),2003,105,,,,,Alemán C; Alegre J; Monasterio J
8,"Scarci M, Abah U, Solli P. EACTS expert consensus statement for surgical management of pleural empyema. Eur J Cardiothorac Surg. 2015;48.",EACTS expert consensus statement for surgical management of pleural empyema,Eur J Cardiothorac Surg,2015,48,,,,,Scarci M; Abah U; Solli P
9,"Guyatt GH, Oxman AD, Kunz R. Going from evidence to recommendations. BMJ. 2008;336.",Going from evidence to recommendations,BMJ,2008,336,,,,,Guyatt GH; Oxman AD; Kunz R
10,"Guyatt GH, Oxman AD, Vist GE. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336.",GRADE: an emerging consensus on rating quality of evidence and strength of recommendations,BMJ,2008,336,,,,,Guyatt GH; Oxman AD; Vist GE
11,"Fink A, Kosecoff J, Chassin M, Brook RH. Consensus methods: characteristics and guidelines for use. Am J Public Health. 1984;74.",Consensus methods: characteristics and guidelines for use,Am J Public Health,1984,74,,,,,Fink A; Kosecoff J; Chassin M; Brook RH
12,"Kwong JS, Chen H, Sun X. Development of evidence-based recommendations: implications for preparing expert consensus statements. Chin Med J (Engl). 2016;129.",Development of evidence-based recommendations: implications for preparing expert consensus statements,Chin Med J (Engl),2016,129,,,,,Kwong JS; Chen H; Sun X
13,"Djulbegovic B, Guyatt G. Evidence vs consensus in clinical practice guidelines. JAMA. 2019;322:725.",Evidence vs consensus in clinical practice guidelines,JAMA,2019,322,,725,,,Djulbegovic B; Guyatt G
14,"Tillett WS, Sherry S. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exudations. J Clin Invest. 1949;28.","The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exudations",J Clin Invest,1949,28,,,,,Tillett WS; Sherry S
15,"Piccolo F, Popowicz N, Wong D, Lee YC. Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection. J Thorac Dis. 2015;7.",Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection,J Thorac Dis,2015,7,,,,,Piccolo F; Popowicz N; Wong D; Lee YC
16,"Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas NM. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med. 1997;155.","Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study",Am J Respir Crit Care Med,1997,155,,,,,Bouros D; Schiza S; Patsourakis G; Chalkiadakis G; Panagou P; Siafakas NM
17,"Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax. 1997;52.",Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection,Thorax,1997,52,,,,,Davies RJ; Traill ZC; Gleeson FV
18,"Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med. 1999;159.","Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study",Am J Respir Crit Care Med,1999,159,,,,,Bouros D; Schiza S; Tzanakis N; Chalkiadakis G; Drositis J; Siafakas N
19,"Tuncozgur B, Ustunsoy H, Sivrikoz MC. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract. 2001;55.",Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial,Int J Clin Pract,2001,55,,,,,Tuncozgur B; Ustunsoy H; Sivrikoz MC
20,"Diacon AH, Schuurmans TJ, Van De Wal MM, Bolliger BW, CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med. 2004;170.",Intrapleural streptokinase for empyema and complicated parapneumonic effusions,Am J Respir Crit Care Med,2004,170,,,,,Diacon AH; Schuurmans TJ; Van De Wal MM; Bolliger BW; CT
21,"Misthos P, Sepsas E, Konstantinou M, Athanassiadi K, Skottis I, Lioulias A. Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study. Eur J Cardiothorac Surg. 2005;28.",Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study,Eur J Cardiothorac Surg,2005,28,,,,,Misthos P; Sepsas E; Konstantinou M; Athanassiadi K; Skottis I; Lioulias A
22,"Prasad B, Bhattacharyya D, Luthra M, Mathur AD. Management of empyema thoracis with pleural pigtail drainage and intrapleural thrombolytic therapy. C. 2009;44.",Management of empyema thoracis with pleural pigtail drainage and intrapleural thrombolytic therapy,C,2009,44,,,,,Prasad B; Bhattacharyya D; Luthra M; Mathur AD
23,"Lin J, Li M, Zhou H, Niu YY, Liu XY. Effectiveness and safety of intrapleural tissue plasminogen activator in the prevention of pleural thickening and loculated pleural effusions. Zhonghua Linchuang Yishi Zazhi. 2011;5.",Effectiveness and safety of intrapleural tissue plasminogen activator in the prevention of pleural thickening and loculated pleural effusions,Zhonghua Linchuang Yishi Zazhi,2011,5,,,,,Lin J; Li M; Zhou H; Niu YY; Liu XY
24,"Thommi G, Shehan JC, Robison KL, Christensen M, Backemeyer LA, Mcleay MT. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions. Respir Med. 2012;106.",A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions,Respir Med,2012,106,,,,,Thommi G; Shehan JC; Robison KL; Christensen M; Backemeyer LA; Mcleay MT
25,"Alemán C, Porcel JM, Alegre J. Intrapleural fibrinolysis with urokinase versus alteplase in complicated parapneumonic pleural effusions and empyemas: a prospective randomized study. Lung. 2015;193.",Intrapleural fibrinolysis with urokinase versus alteplase in complicated parapneumonic pleural effusions and empyemas: a prospective randomized study,Lung,2015,193,,,,,Alemán C; Porcel JM; Alegre J
26,"Altmann ES, Crossingham I, Wilson S, Davies HR. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev. 2019;10:2312.","Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema",Cochrane Database Syst Rev,2019,10,,2312,,,Altmann ES; Crossingham I; Wilson S; Davies HR
27,"Wait MA, Sharma S, Hohn J, Nogare D, A. A randomized trial of empyema therapy. Chest. 1997;111.",A randomized trial of empyema therapy,Chest,1997,111,,,,,Wait MA; Sharma S; Hohn J; Nogare D; A
28,"Nie W, Liu Y, Ye J. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials. Clin Respir J. 2014;8.",Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials,Clin Respir J,2014,8,,,,,Nie W; Liu Y; Ye J
29,"Bédat B, Plojoux J, Noel J. Comparison of intrapleural use of urokinase and tissue plasminogen activator/DNAse in pleural infection. ERJ Open Res. 2019;5.",Comparison of intrapleural use of urokinase and tissue plasminogen activator/DNAse in pleural infection,ERJ Open Res,2019,5,,,,,Bédat B; Plojoux J; Noel J
30,"Beckert L, Brockway B, Simpson G. Phase 1 trial of intrapleural LTI-01; single chain urokinase in complicated parapneumonic effusions or empyema. JCI Insight. 2019;5:5.",Phase 1 trial of intrapleural LTI-01; single chain urokinase in complicated parapneumonic effusions or empyema,JCI Insight,2019,5,,5,,,Beckert L; Brockway B; Simpson G
31,"Light RW, Nguyen T, Mulligan ME, Sasse SA. The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema. Lung. 2000;178.",The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema,Lung,2000,178,,,,,Light RW; Nguyen T; Mulligan ME; Sasse SA
32,"Zhu Z, Hawthorne ML, Guo Y. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. Chest. 2006;129.",Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model,Chest,2006,129,,,,,Zhu Z; Hawthorne ML; Guo Y
33,"Hooper CE, Edey AJ, Wallis A. Pleural irrigation trial (PIT): a randomised controlled trial of pleural irrigation with normal saline versus standard care in patients with pleural infection. Eur Respir J. 2015;46.",Pleural irrigation trial (PIT): a randomised controlled trial of pleural irrigation with normal saline versus standard care in patients with pleural infection,Eur Respir J,2015,46,,,,,Hooper CE; Edey AJ; Wallis A
34,"Lansley SM, Cheah HM, Varano D, Vergiliana JF, Chakera A, Lee YC. Tissue plasminogen activator potently stimulates pleural effusion via a monocyte chemotactic protein-1-dependent mechanism. Am J Respir Cell Mol Biol. 2015;53.",Tissue plasminogen activator potently stimulates pleural effusion via a monocyte chemotactic protein-1-dependent mechanism,Am J Respir Cell Mol Biol,2015,53,,,,,Lansley SM; Cheah HM; Varano D; Vergiliana JF; Chakera A; Lee YC
35,"Kanellakis NI, Wrightson JM, Hallifax R. Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients. BMJ Open Respir Res. 2019;6:e000440.",Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients,BMJ Open Respir Res,2019,6,,e000440,,,Kanellakis NI; Wrightson JM; Hallifax R
36,"Hall-Stoodley L, Nistico L, Sambanthamoorthy K. Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates. BMC Microbiol. 2008;8:173.","Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates",BMC Microbiol,2008,8,,173,,,Hall-Stoodley L; Nistico L; Sambanthamoorthy K
37,"Piccolo F, Pitman N, Bhatnagar R. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery. Ann Am Thorac Soc. 2014;11.",Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery,Ann Am Thorac Soc,2014,11,,,,,Piccolo F; Pitman N; Bhatnagar R
38,"Mehta HJ, Biswas A, Penley AM, Cope J, Barnes M, Jantz MA. Management of intrapleural sepsis with once daily use of tissue plasminogen activator and deoxyribonuclease. Respiration. 2016;91.",Management of intrapleural sepsis with once daily use of tissue plasminogen activator and deoxyribonuclease,Respiration,2016,91,,,,,Mehta HJ; Biswas A; Penley AM; Cope J; Barnes M; Jantz MA
39,"Majid A, Kheir F, Folch A. Concurrent intrapleural instillation of tissue plasminogen activator and DNase for pleural infection. A single-center experience. Ann Am Thorac Soc. 2016;13.",Concurrent intrapleural instillation of tissue plasminogen activator and DNase for pleural infection. A single-center experience,Ann Am Thorac Soc,2016,13,,,,,Majid A; Kheir F; Folch A
40,"Mcclune JR, Wilshire CL, Gorden JA. Safety and efficacy of intrapleural tissue plasminogen activator and DNase during extended use in complicated pleural space infections. Can Respir J. 2016;2016:9796768.",Safety and efficacy of intrapleural tissue plasminogen activator and DNase during extended use in complicated pleural space infections,Can Respir J,2016,2016,,9796768,,,Mcclune JR; Wilshire CL; Gorden JA
41,"Popowicz N, Bintcliffe O, Fonseka D, D. Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The alteplase dose assessment for pleural infection therapy project. Ann Am Thorac Soc. 2017;14.",Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The alteplase dose assessment for pleural infection therapy project,Ann Am Thorac Soc,2017,14,,,,,Popowicz N; Bintcliffe O; Fonseka D; D
42,"Fysh E, Tremblay A, Feller-Kopman D. Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study. Chest. 2013;144.",Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study,Chest,2013,144,,,,,Fysh E; Tremblay A; Feller-Kopman D
43,"Simpson G, Roomes D, Reeves B. Successful treatment of empyema thoracis with human recombinant deoxyribonuclease. Thorax. 2003;58.",Successful treatment of empyema thoracis with human recombinant deoxyribonuclease,Thorax,2003,58,,,,,Simpson G; Roomes D; Reeves B
44,"Innabi A, Surana A, Alzghoul B, Meena N. Rethinking the doses of tissue plasminogen activator and deoxyribonuclease administrated concurrently for intrapleural therapy for complicated pleural effusion and empyema. Cureus. 2018;10:e2214.",Rethinking the doses of tissue plasminogen activator and deoxyribonuclease administrated concurrently for intrapleural therapy for complicated pleural effusion and empyema,Cureus,2018,10,,e2214,,,Innabi A; Surana A; Alzghoul B; Meena N
45,"Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120.",Fixed-dose combinations improve medication compliance: a meta-analysis,Am J Med,2007,120,,,,,Bangalore S; Kamalakkannan G; Parkar S; Messerli FH
46,"Kheir F, Cheng G, Rivera E. Concurrent versus sequential intrapleural instillation of tissue plasminogen activator and deoxyribonuclease for pleural infection. J Bronchology Interv Pulmonol. 2018;25.",Concurrent versus sequential intrapleural instillation of tissue plasminogen activator and deoxyribonuclease for pleural infection,J Bronchology Interv Pulmonol,2018,25,,,,,Kheir F; Cheng G; Rivera E
47,"Thakkar DH, Halligan K, Rechache K, Agameya A, Lamb C. De-mist-ifying intrapleural lytic therapy dosing. Chest. 2017;None.",De-mist-ifying intrapleural lytic therapy dosing,Chest,2017,,,,,,Thakkar DH; Halligan K; Rechache K; Agameya A; Lamb C
48,"Bishwakarma R, Shah S, Frank L, Zhang W, Sharma G, Nishi SP. Mixing it up: coadministration of tPA/DNase in complicated parapneumonic pleural effusions and empyema. J Bronchology Interv Pulmonol. 2017;24.",Mixing it up: coadministration of tPA/DNase in complicated parapneumonic pleural effusions and empyema,J Bronchology Interv Pulmonol,2017,24,,,,,Bishwakarma R; Shah S; Frank L; Zhang W; Sharma G; Nishi SP
49,"Heimes J, Copeland H, Lulla A. The use of thrombolytics in the management of complex pleural fluid collections. J Thorac Dis. 2017;9.",The use of thrombolytics in the management of complex pleural fluid collections,J Thorac Dis,2017,9,,,,,Heimes J; Copeland H; Lulla A
50,"Hamblin SE, Furmanek DL. Intrapleural tissue plasminogen activator for the treatment of parapneumonic effusion. Pharmacotherapy. 2010;30.",Intrapleural tissue plasminogen activator for the treatment of parapneumonic effusion,Pharmacotherapy,2010,30,,,,,Hamblin SE; Furmanek DL
51,"Hallifax RJ, Psallidas I, Rahman NM. Chest drain size: the debate continues. Curr Pulmonol Rep. 2017;6.",Chest drain size: the debate continues,Curr Pulmonol Rep,2017,6,,,,,Hallifax RJ; Psallidas I; Rahman NM
52,"Mcloud TC, Flower CD. Imaging the pleura: sonography, CT, and MR imaging. AJR Am J Roentgenol. 1991;156.","Imaging the pleura: sonography, CT, and MR imaging",AJR Am J Roentgenol,1991,156,,,,,Mcloud TC; Flower CD
53,"Davies CW, Lok S, Davies RJ. The systemic fibrinolytic activity of intrapleural streptokinase. Am J Respir Crit Care Med. 1998;157.",The systemic fibrinolytic activity of intrapleural streptokinase,Am J Respir Crit Care Med,1998,157,,,,,Davies CW; Lok S; Davies RJ
54,"Gervais DA, Levis DA, Hahn PF, Uppot RN, Arellano RS, Mueller PR. Adjunctive intrapleural tissue plasminogen activator administered via chest tubes placed with imaging guidance: effectiveness and risk for hemorrhage. Radiology. 2008;246.",Adjunctive intrapleural tissue plasminogen activator administered via chest tubes placed with imaging guidance: effectiveness and risk for hemorrhage,Radiology,2008,246,,,,,Gervais DA; Levis DA; Hahn PF; Uppot RN; Arellano RS; Mueller PR
55,Godfrey M. Nondraining indwelling pleural catheters in malignant pleural effusion: how safe is fibrinolysis in patients at high risk of bleeding? American Thoracic Society. Nondraining indwelling pleural catheters in malignant pleural effusion: how safe is fibrinolysis in patients at high risk of bleeding? American Thoracic Society. 2019;None.,Nondraining indwelling pleural catheters in malignant pleural effusion: how safe is fibrinolysis in patients at high risk of bleeding? American Thoracic Society,Nondraining indwelling pleural catheters in malignant pleural effusion: how safe is fibrinolysis in patients at high risk of bleeding? American Thoracic Society,2019,,,,,,Godfrey M
56,"Bilgin M, Akcali Y, Oguzkaya F. Benefits of early aggressive management of empyema thoracis. ANZ J Surg. 2006;76.",Benefits of early aggressive management of empyema thoracis,ANZ J Surg,2006,76,,,,,Bilgin M; Akcali Y; Oguzkaya F
57,"Samancilar O, Akçam TI, Kaya SO, Ozturk O, Akcay O, Ceylan KC. The efficacy of VATS and intrapleural fibrinolytic therapy in parapneumonic empyema treatment. Ann Thorac Cardiovasc Surg. 2018;24.",The efficacy of VATS and intrapleural fibrinolytic therapy in parapneumonic empyema treatment,Ann Thorac Cardiovasc Surg,2018,24,,,,,Samancilar O; Akçam TI; Kaya SO; Ozturk O; Akcay O; Ceylan KC
58,"Elsayed HH, Mostafa A, Fathy E. Thoracoscopic management of early stages of empyema: is this the golden standard?. J Vis Surg. 2018;4:114.",Thoracoscopic management of early stages of empyema: is this the golden standard?,J Vis Surg,2018,4,,114,,,Elsayed HH; Mostafa A; Fathy E
59,"Kheir F, Thakore S, Mehta H. Intrapleural fibrinolytic therapy versus early medical thoracoscopy for treatment of pleural infection. Ann Am Thorac Soc. 2020;17.",Intrapleural fibrinolytic therapy versus early medical thoracoscopy for treatment of pleural infection,Ann Am Thorac Soc,2020,17,,,,,Kheir F; Thakore S; Mehta H
60,"Lardinois D, Gock M, Pezzetta E. Delayed referral and gram-negative organisms increase the conversion thoracotomy rate in patients undergoing video-assisted thoracoscopic surgery for empyema. Ann Thorac Surg. 2005;79.",Delayed referral and gram-negative organisms increase the conversion thoracotomy rate in patients undergoing video-assisted thoracoscopic surgery for empyema,Ann Thorac Surg,2005,79,,,,,Lardinois D; Gock M; Pezzetta E
61,"Stefani A, Aramini B, Della Casa G. Preoperative predictors of successful surgical treatment in the management of parapneumonic empyema. Ann Thorac Surg. 2013;96.",Preoperative predictors of successful surgical treatment in the management of parapneumonic empyema,Ann Thorac Surg,2013,96,,,,,Stefani A; Aramini B; Della Casa G
62,"Jagelavicius Z, Jovaisas V, Mataciunas M, Samalavicius NE, Janilionis R. Preoperative predictors of conversion in thoracoscopic surgery for pleural empyema. Eur J Cardiothorac Surg. 2017;52.",Preoperative predictors of conversion in thoracoscopic surgery for pleural empyema,Eur J Cardiothorac Surg,2017,52,,,,,Jagelavicius Z; Jovaisas V; Mataciunas M; Samalavicius NE; Janilionis R
63,"Chambers A, Routledge T, Dunning J, Scarci M. Is video-assisted thoracoscopic surgical decortication superior to open surgery in the management of adults with primary empyema?. Interact Cardiovasc Thorac Surg. 2010;11.",Is video-assisted thoracoscopic surgical decortication superior to open surgery in the management of adults with primary empyema?,Interact Cardiovasc Thorac Surg,2010,11,,,,,Chambers A; Routledge T; Dunning J; Scarci M
64,"Shoseyov D, Bibi H, Shatzberg G. Short-term course and outcome of treatments of pleural empyema in pediatric patients: repeated ultrasound-guided needle thoracocentesis vs chest tube drainage. Chest. 2002;121.",Short-term course and outcome of treatments of pleural empyema in pediatric patients: repeated ultrasound-guided needle thoracocentesis vs chest tube drainage,Chest,2002,121,,,,,Shoseyov D; Bibi H; Shatzberg G
65,"Farjah F, Symons RG, Krishnadasan B, Wood DE, Flum DR. Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg. 2007;133.",Management of pleural space infections: a population-based analysis,J Thorac Cardiovasc Surg,2007,133,,,,,Farjah F; Symons RG; Krishnadasan B; Wood DE; Flum DR
66,"Tong BC, Hanna J, Toloza EM. Outcomes of video-assisted thoracoscopic decortication. Ann Thorac Surg. 2010;89.",Outcomes of video-assisted thoracoscopic decortication,Ann Thorac Surg,2010,89,,,,,Tong BC; Hanna J; Toloza EM
67,"Sanders GD, Neumann PJ, Basu A. Recommendations for conduct, methodological practices, and reporting of costeffectiveness analyses: second panel on cost-effectiveness in health and medicine. Alteplase: drug information. 2016;316.","Recommendations for conduct, methodological practices, and reporting of costeffectiveness analyses: second panel on cost-effectiveness in health and medicine",Alteplase: drug information,2016,316,,,,,Sanders GD; Neumann PJ; Basu A
68,"Luengo-Fernandez R, Penz E, Dobson M. Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial. Eur Respir J. 2019;54:1801550.",Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial,Eur Respir J,2019,54,,1801550,,,Luengo-Fernandez R; Penz E; Dobson M
69,"Cardillo G, Carleo F, Carbone L. Chronic postpneumonic pleural empyema: comparative merits of thoracoscopic versus open decortication. Eur J Cardiothorac Surg. 2009;36.",Chronic postpneumonic pleural empyema: comparative merits of thoracoscopic versus open decortication,Eur J Cardiothorac Surg,2009,36,,,,,Cardillo G; Carleo F; Carbone L
70,"Marks DJ, Fisk MD, Koo CY. Management of complicated parapneumonic effusion and empyema using different treatment modalities. Asian Cardiovasc Thorac Ann. 2012;7.",Management of complicated parapneumonic effusion and empyema using different treatment modalities,Asian Cardiovasc Thorac Ann,2012,7,,,,,Marks DJ; Fisk MD; Koo CY
71,"Mackinlay A, Lyons TA, Chimondeguy GA et al.. VATS debridement versus thoracotomy in the treatment of loculated postpneumonia empyema. Ann Thorac Surg. 1996;61.",VATS debridement versus thoracotomy in the treatment of loculated postpneumonia empyema,Ann Thorac Surg,1996,61,,,,,Mackinlay A; Lyons TA; Chimondeguy GA; Piedras DJ; Angaramo MA; Emery G; J
72,"Casali C, Storelli ES, Prima D, Morandi E, U. Long-term functional results after surgical treatment of parapneumonic thoracic empyema. Interact Cardiovasc Thorac Surg. 2009;9.",Long-term functional results after surgical treatment of parapneumonic thoracic empyema,Interact Cardiovasc Thorac Surg,2009,9,,,,,Casali C; Storelli ES; Prima D; Morandi E; U
73,"Chan DT, Sihoe AD, Chan S. Surgical treatment for empyema thoracis: is video-assisted thoracic surgery ""better"" than thoracotomy?. Ann Thorac Surg. 2007;84.","Surgical treatment for empyema thoracis: is video-assisted thoracic surgery ""better"" than thoracotomy?",Ann Thorac Surg,2007,84,,,,,Chan DT; Sihoe AD; Chan S
74,"Chung JH, Lee SH, Kim KT, Jung JS, Son HS, Sun K. Optimal timing of thoracoscopic drainage and decortication for empyema. Ann Thorac Surg. 2014;97.",Optimal timing of thoracoscopic drainage and decortication for empyema,Ann Thorac Surg,2014,97,,,,,Chung JH; Lee SH; Kim KT; Jung JS; Son HS; Sun K
75,"Drain AJ, Ferguson JI, Sayeed R, Wilkinson S, RA. Definitive management of advanced empyema by two-window video-assisted surgery. Asian Cardiovasc Thorac Ann. 2007;15.",Definitive management of advanced empyema by two-window video-assisted surgery,Asian Cardiovasc Thorac Ann,2007,15,,,,,Drain AJ; Ferguson JI; Sayeed R; Wilkinson S; RA
76,"Kim BY, Oh BS, Jang WC, Min YI, Park YK, Park JC. Video-assisted thoracoscopic decortication for management of postpneumonic pleural empyema. Am J Surg. 2004;188.",Video-assisted thoracoscopic decortication for management of postpneumonic pleural empyema,Am J Surg,2004,188,,,,,Kim BY; Oh BS; Jang WC; Min YI; Park YK; Park JC
77,"Lawrence DR, Ohri SK, Moxon RE, Townsend ER, Fountain SW. Thoracoscopic debridement of empyema thoracis. Ann Thorac Surg. 1997;64.",Thoracoscopic debridement of empyema thoracis,Ann Thorac Surg,1997,64,,,,,Lawrence DR; Ohri SK; Moxon RE; Townsend ER; Fountain SW
78,"Luh SP, Chou MC, Wang LS, Chen JY, Tsai TP. Video-assisted thoracoscopic surgery in the treatment of complicated parapneumonic effusions or empyemas: outcome of 234 patients. Chest. 2005;127.",Video-assisted thoracoscopic surgery in the treatment of complicated parapneumonic effusions or empyemas: outcome of 234 patients,Chest,2005,127,,,,,Luh SP; Chou MC; Wang LS; Chen JY; Tsai TP
79,"Podbielski FJ, Maniar HS, Rodriguez HE, Hernan MJ, Vigneswaran WT. Surgical strategy of complex empyema thoracis. JSLS. 2000;4.",Surgical strategy of complex empyema thoracis,JSLS,2000,4,,,,,Podbielski FJ; Maniar HS; Rodriguez HE; Hernan MJ; Vigneswaran WT
80,Roberts JR. Minimally invasive surgery in the treatment of empyema: intraoperative decision making. Ann Thorac Surg. 2003;76.,Minimally invasive surgery in the treatment of empyema: intraoperative decision making,Ann Thorac Surg,2003,76,,,,,Roberts JR
81,"Solaini L, Prusciano F, Bagioni P. Video-assisted thoracic surgery in the treatment of pleural empyema. Surg Endosc. 2007;21.",Video-assisted thoracic surgery in the treatment of pleural empyema,Surg Endosc,2007,21,,,,,Solaini L; Prusciano F; Bagioni P
82,"Striffeler H, Gugger M, Hof I et al.. Video-assisted thoracoscopic surgery for fibrinopurulent pleural empyema in 67 patients. Ann Thorac Surg. 1998;65.",Video-assisted thoracoscopic surgery for fibrinopurulent pleural empyema in 67 patients,Ann Thorac Surg,1998,65,,,,,Striffeler H; Gugger M; Hof I; Cerny V; Furrer A; Ris M; HB
83,"Waller DA, Rengarajan A. Thoracoscopic decortication: a role for video-assisted surgery in chronic postpneumonic pleural empyema. Ann Thorac Surg. 2001;71.",Thoracoscopic decortication: a role for video-assisted surgery in chronic postpneumonic pleural empyema,Ann Thorac Surg,2001,71,,,,,Waller DA; Rengarajan A
84,"Li ST, Gates RL. Primary operative management for pediatric empyema: decreases in hospital length of stay and charges in a national sample. Arch Pediatr Adolesc Med. 2008;162.",Primary operative management for pediatric empyema: decreases in hospital length of stay and charges in a national sample,Arch Pediatr Adolesc Med,2008,162,,,,,Li ST; Gates RL
85,"Mennander A, Laurikka J, Kuukasjarvi P, Tarkka M. Continuous pleural lavage may decrease postoperative morbidity in patients undergoing thoracotomy for stage 2 thoracic empyema. Eur J Cardiothorac Surg. 2005;27.",Continuous pleural lavage may decrease postoperative morbidity in patients undergoing thoracotomy for stage 2 thoracic empyema,Eur J Cardiothorac Surg,2005,27,,,,,Mennander A; Laurikka J; Kuukasjarvi P; Tarkka M
86,"Simmers TA, Jie C, Sie B. Minimally invasive treatment of thoracic empyema. Thorac Cardiovasc Surg. 1999;47.",Minimally invasive treatment of thoracic empyema,Thorac Cardiovasc Surg,1999,47,,,,,Simmers TA; Jie C; Sie B
87,"Karmy-Jones R, Sorenson V, Horst HM, Lewis JW, Jr, Rubinfeld I. Rigid thorascopic debridement and continuous pleural irrigation in the management of empyema. Chest. 1997;111.",Rigid thorascopic debridement and continuous pleural irrigation in the management of empyema,Chest,1997,111,,,,,Karmy-Jones R; Sorenson V; Horst HM; Lewis JW; Jr; Rubinfeld I
88,"Brutsche MH, Tassi GF, Györik S. Treatment of sonographically stratified multiloculated thoracic empyema by medical thoracoscopy. Chest. 2005;128.",Treatment of sonographically stratified multiloculated thoracic empyema by medical thoracoscopy,Chest,2005,128,,,,,Brutsche MH; Tassi GF; Györik S
